- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05130736
Rehabilitation Robot in Patients With Post-Coronavirus Disease (COVID-19) Fatigue Syndrome
The Use of a Rehabilitation Robot in Patients With Post-COVID-19 Fatigue Syndrome
The aim of the study is to compare the effectiveness of two models of rehabilitation:
- traditional neurological rehabilitation, and
- neurological rehabilitation combined with a rehabilitation robot (Luna by EGZOTech).
An additional goal is to test the qualitative diagnostic reference using the surface electromyogram of the Luna robot (certified as a Medical Device) for functional diagnostics based on standardized clinical tests.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Katarzyna Hojan, MD, PhD
- Phone Number: +48618546573
- Email: khojan@ump.edu.pl
Study Contact Backup
- Name: Slawomir Tobis, PhD
- Phone Number: +48618546573
- Email: stobis@ump.edu.pl
Study Locations
-
-
-
Poznań, Poland, 60-781
- Recruiting
- Poznan University of Medical Sciences
-
Contact:
- Katarzyna Hojan, MD, PhD
- Phone Number: +48618546573
- Email: khojan@ump.edu.pl
-
Contact:
- Slawomir Tobis, PhD
- Phone Number: +48618546573
- Email: stobis@ump.edu.pl
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patients discharged from Intensive Care Units after undergone ventilator therapy due to COVID-19
Exclusion Criteria:
- active medical condition (infections; tumors; rheumatological, metabolic, endocrine, autoimmunological, cardiovascular diseases)
- bipolar disorder
- dementia
- nutritional disorders
- addiction to alcohol or psychoactive substances
- severe obesity
- overtraining
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Robot
Patients treated using a rehabilitation robot
|
Effectiveness of using a rehabilitation robot in post-COVID-19 rehabilitation
|
Active Comparator: Control
Patients receiving traditional rehabilitation treatment (robot used only as assessment tool)
|
Effectiveness of using a rehabilitation robot in post-COVID-19 rehabilitation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in muscle fatigue assessment
Time Frame: Baseline, after 3 and after 8 weeks
|
Raw robot measurement data (isometric contraction of the muscle for 60 s - biceps, quadriceps)
|
Baseline, after 3 and after 8 weeks
|
Change in isokinetic muscle force
Time Frame: Baseline, after 3 and after 8 weeks
|
Raw robot measurement data (5 repetitions during measurement with LUNA)
|
Baseline, after 3 and after 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in functional physical ability 1
Time Frame: Baseline, after 3 and after 8 weeks
|
Functional Independence Measure
|
Baseline, after 3 and after 8 weeks
|
Change in functional physical ability 2
Time Frame: Baseline, after 3 and after 8 weeks
|
Barthel Index
|
Baseline, after 3 and after 8 weeks
|
Change in functional physical ability 3
Time Frame: Baseline, after 3 and after 8 weeks
|
Berg Balance Test
|
Baseline, after 3 and after 8 weeks
|
Change in functional physical ability 4
Time Frame: Baseline, after 3 and after 8 weeks
|
Short Physical Performance Battery
|
Baseline, after 3 and after 8 weeks
|
Change in cognitive ability 1
Time Frame: Baseline, after 3 and after 8 weeks
|
Addenbrooke's Cognitive Examination (ACE-III)
|
Baseline, after 3 and after 8 weeks
|
Change in cognitive ability 2
Time Frame: Baseline, after 3 and after 8 weeks
|
Montreal Cognitive Assessment
|
Baseline, after 3 and after 8 weeks
|
Change in the quality of life
Time Frame: Baseline, after 3 and after 8 weeks
|
WHOQOL
|
Baseline, after 3 and after 8 weeks
|
Change in depressive symptoms
Time Frame: Baseline, after 3 and after 8 weeks
|
Beck's Depression Inventory
|
Baseline, after 3 and after 8 weeks
|
Collaborators and Investigators
Investigators
- Study Chair: Katarzyna Hojan, MD, PhD, Poznan University of Medical Sciences
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 514/21
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post-Viral Fatigue Syndrome
-
University of Dublin, Trinity CollegeScience Foundation IrelandCompletedCovid19 | Post Viral FatigueIreland
-
Luis NaculUniversity of British Columbia; Canadian Institutes of Health Research (CIHR); Provincial Health Services Authority and other collaboratorsRecruiting
-
Medical University of ViennaRecruitingViral Myocarditis | POTS | Post Viral FatigueAustria
-
University Hospital TuebingenCharite University, Berlin, Germany; Robert Bosch Gesellschaft für Medizinische...RecruitingPost-COVID-19 Syndrome | Fatigue Post ViralGermany
-
IMMUNOe Research CentersUnknownCovid19 | Post-Viral Fatigue Syndrome | Post-Viral Disorder (Disorder)United States
-
Sunnybrook Health Sciences CentreNot yet recruitingCOVID-19 | Fatigue | Fatigue Syndrome, Chronic | Post-COVID-19 Syndrome | Post COVID-19 Condition | Post-COVID SyndromeCanada
-
Université de SherbrookeHotel Dieu HospitalCompletedChronic Fatigue Syndrome | Long COVIDCanada
-
ClinAmygateAs-Salam Center, Maadi, Cairo, EgyptRecruiting
-
Centre Hospitalier Universitaire de Saint EtienneRecruitingPost Intensive Care SyndromeFrance
-
Terra Biological LLCBateman Horne CenterRecruitingFatigue Syndrome, Chronic | Post-COVID-19 SyndromeUnited States
Clinical Trials on Robot rehabilitation
-
National Rehabilitation Center, Seoul, KoreaRecruitingStrokeKorea, Republic of
-
University of CalgaryUnknownHemiplegic Cerebral Palsy | Perinatal StrokeCanada
-
Universiti Teknologi MalaysiaNational Stroke Association of Malaysia (NASAM); Collaborative Research in... and other collaboratorsCompleted
-
Ankara City Hospital BilkentRecruitingCerebral Palsy | Upper Extremity ProblemTurkey
-
The Hong Kong Polytechnic UniversityRecruiting
-
Northwell HealthRecruitingStroke | HemiparesisUnited States
-
Taipei Medical University Shuang Ho HospitalCompletedCerebral PalsyTaiwan
-
Roger GassertCompletedStroke | Upper Extremity ParesisSwitzerland
-
University Hospital, BrestCompleted